FC-GAMMA-RII/III AND CD2 EXPRESSION MARK DISTINCT SUBPOPULATIONS OF IMMATURE CD4-CD8-MURINE THYMOCYTES - INVIVO DEVELOPMENTAL KINETICS AND T-CELL RECEPTOR BETA-CHAIN REARRANGEMENT STATUS

被引:92
作者
RODEWALD, HR
AWAD, K
MOINGEON, P
DADAMIO, L
RABINOWITZ, D
SHINKAI, Y
ALT, FW
REINHERZ, EL
机构
[1] HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH PUBL HLTH, DEPT BIOSTAT, BOSTON, MA 02115 USA
[4] CHILDRENS HOSP MED CTR, HOWARD HUGHES MED INST, BOSTON, MA 02115 USA
关键词
D O I
10.1084/jem.177.4.1079
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have recently identified a dominant wave of CD4-CD8- (double-negative [DN]) thymocytes in early murine fetal development that express low affinity Fcgamma receptors (FcgammaRII/III) and contain precursors for Tialpha/beta lineage T cells. Here we show that FcgammaRII/III is expressed in very immature CD4low single-positive (SP) thymocytes and that FcgammaRII/III expression is downregulated within the DN subpopulation and before the CD3-CD8low SP stage in T cell receptor (TCR)-alpha/beta lineage-committed thymocytes. DN FcgammaRII/III+ thymocytes also contain a small fraction of TCR-gamma/delta lineage cells in addition to TCR-alpha/beta progenitors. Fetal day 15.5 DN TCR-alpha/beta lineage progenitors can be subdivided into three major subpopulations as characterized by cell surface expression of FcgammaRII/III vs. CD2 (FcgammaRII/III+CD2-, FcgammaRII/III+CD2+, FcgammaRII/III-CD2+). Phenotypic analysis during fetal development as well as adoptive transfer of isolated fetal thymocyte subpopulations derived from C57Bl/6 (Ly5.1) mice into normal, nonirradiated Ly5.2 congenic recipient mice identifies one early differentiation sequence (FcgammaRII/III+CD2- --> FcgammaRII/III+CD2+ --> FcgammaRII/III-CD2+) that precedes the entry of DN thymocytes into the CD4+CD8+ double-positive (DP) TCR(low/-) stage. Unseparated day 15.5 fetal thymocytes develop into DP thymocytes within 2.5 d and remain at the DP stage for >48 h before being selected into either CD4+ or CD8+ SP thymocytes. In contrast, FcgammaRII/III+CD2- DN thymocytes follow this same developmental pathway but are delayed by approximately 24 h before entering the DP compartment, while FcgammaRII/III-CD2+ display accelerated development by approximately 24 h compared with total day 15.5 thymocytes. FCgammaRII/III-CD2+ are also more developmentally advanced than FcgammaRII/III+CD2- fetal thymocytes with respect to their TCR beta chain V(D)J rearrangement. At day 15.5 in gestation, beta chain V(D)J rearrangement is mostly, if not entirely, restricted to the FcgammaRII/III-CD2+ subset of DN fetal thymocytes. Consistent with this analysis in fetal thymocytes, >90% of adult thymocytes derived from mice carrying a disrupting mutation at the recombination-activating gene 2 locus (RAG-2-/-) on both alleles are developmentally arrested at the DN CD2- stage. In addition, there is a fivefold increase in the relative percentage of thymocytes expressing FcgammaRII/III in TCR and immunoglobulin gene rearrangement-incompetent homozygous RAG-2-/- mice (15% FcgammaRII/III+) versus rearrangement-competent heterozygous RAG-2+/- mice (<3% FcgammaRII/III+). Thus, FcgammaRII/III expression defines an early DN stage preceding V(beta)(D(beta))J(beta) rearrangement, which in turn is followed by surface expression of CD2. Loss of FcgammaRII/III and acquisition of CD2 expression characterize a late DN stage immediately before the conversion into DP thymocytes.
引用
收藏
页码:1079 / 1092
页数:14
相关论文
共 66 条
[1]   EARLY EVENTS IN T-CELL MATURATION [J].
ADKINS, B ;
MUELLER, C ;
OKADA, CY ;
REICHERT, RA ;
WEISSMAN, IL ;
SPANGRUDE, GJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1987, 5 :325-365
[2]   VDJ RECOMBINATION [J].
ALT, FW ;
OLTZ, EM ;
YOUNG, F ;
GORMAN, J ;
TACCIOLI, G ;
CHEN, J .
IMMUNOLOGY TODAY, 1992, 13 (08) :306-314
[3]   FC-GAMMA RECEPTOR TYPE-III (CD16) IS INCLUDED IN THE ZETA-NK RECEPTOR COMPLEX EXPRESSED BY HUMAN NATURAL-KILLER-CELLS [J].
ANDERSON, P ;
CALIGIURI, M ;
OBRIEN, C ;
MANLEY, T ;
RITZ, J ;
SCHLOSSMAN, SF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) :2274-2278
[4]  
[Anonymous], 1986, MANIPULATING MOUSE E
[5]   THE SCID MOUSE MUTANT - DEFINITION, CHARACTERIZATION, AND POTENTIAL USES [J].
BOSMA, MJ ;
CARROLL, AM .
ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 :323-350
[6]  
BRUCE J, 1981, J IMMUNOL, V127, P2496
[7]   B220 - A B-CELL-SPECIFIC MEMBER OF THE T200 GLYCOPROTEIN FAMILY [J].
COFFMAN, RL ;
WEISSMAN, IL .
NATURE, 1981, 289 (5799) :681-683
[8]  
Cox D.R., 1974, THEORETICAL STAT
[9]   DIFFERENTIATION POTENTIAL OF SUBSETS OF CD4-8- THYMOCYTES [J].
CRISPE, IN ;
MOORE, MW ;
HUSMANN, LA ;
SMITH, L ;
BEVAN, MJ ;
SHIMONKEVITZ, RP .
NATURE, 1987, 329 (6137) :336-339
[10]  
CRISPE IN, 1987, J IMMUNOL, V138, P2013